Mollion H - Search Results

1

The timing of antiparkinsonian treatment reduction after subthalamic nucleus stimulation.

Thobois S, Corvaisier S, Mertens P, Di Guardo C, Mollion H, Guenot M, Rochefort F, Chazot G, Sindou M, Broussolle E. Thobois S, et al. Among authors: mollion h. Eur Neurol. 2003;49(1):59-63. doi: 10.1159/000067028. Eur Neurol. 2003. PMID: 12464720

2

Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic study.

Thobois S, Vingerhoets F, Fraix V, Xie-Brustolin J, Mollion H, Costes N, Mertens P, Benabid AL, Pollak P, Broussolle E. Thobois S, et al. Among authors: mollion h. Arch Neurol. 2004 Nov;61(11):1705-9. doi: 10.1001/archneur.61.11.1705. Arch Neurol. 2004. PMID: 15534182 Clinical Trial.

3

Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: three years follow-up.

Gan J, Xie-Brustolin J, Mertens P, Polo G, Klinger H, Mollion H, Benatru I, Henry E, Broussolle E, Thobois S. Gan J, et al. Among authors: mollion h. J Neurol. 2007 Jan;254(1):99-106. doi: 10.1007/s00415-006-0297-6. Epub 2007 Feb 14. J Neurol. 2007. PMID: 17508144

4

Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients.

Thobois S, Mertens P, Guenot M, Hermier M, Mollion H, Bouvard M, Chazot G, Broussolle E, Sindou M. Thobois S, et al. Among authors: mollion h. J Neurol. 2002 May;249(5):529-34. doi: 10.1007/s004150200059. J Neurol. 2002. PMID: 12021940 Clinical Trial.

5

Subthalamic nucleus stimulation selectively improves motor and visual memory performance in Parkinson's disease.

Mollion H, Dominey PF, Broussolle E, Ventre-Dominey J. Mollion H, et al. Mov Disord. 2011 Sep;26(11):2019-25. doi: 10.1002/mds.23769. Epub 2011 May 24. Mov Disord. 2011. PMID: 21611980

6

Distinct effects of dopamine vs STN stimulation therapies in associative learning and retention in Parkinson disease.

Ventre-Dominey J, Mollion H, Thobois S, Broussolle E. Ventre-Dominey J, et al. Among authors: mollion h. Behav Brain Res. 2016 Apr 1;302:131-41. doi: 10.1016/j.bbr.2016.01.010. Epub 2016 Jan 8. Behav Brain Res. 2016. PMID: 26778783

7

Dissociable effects of dopaminergic therapy on spatial versus non-spatial working memory in Parkinson's disease.

Mollion H, Ventre-Dominey J, Dominey PF, Broussolle E. Mollion H, et al. Neuropsychologia. 2003;41(11):1442-51. doi: 10.1016/s0028-3932(03)00114-3. Neuropsychologia. 2003. PMID: 12849762 Clinical Trial.

8

Dissociable dorsal and ventral frontostriatal working memory circuits: evidence from subthalamic stimulation in Parkinson's disease.

Ventre-Dominey J, Bourret S, Mollion H, Broussolle E, Dominey PF. Ventre-Dominey J, et al. Among authors: mollion h. Hum Brain Mapp. 2014 Feb;35(2):552-66. doi: 10.1002/hbm.22205. Epub 2012 Oct 25. Hum Brain Mapp. 2014. PMID: 23097317 Free PMC article.

9

Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study.

Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN; NNIPPS Study Group. Bensimon G, et al. Brain. 2009 Jan;132(Pt 1):156-71. doi: 10.1093/brain/awn291. Epub 2008 Nov 23. Brain. 2009. PMID: 19029129 Free PMC article. Clinical Trial.

10

CSF biomarkers in posterior cortical atrophy.

Seguin J, Formaglio M, Perret-Liaudet A, Quadrio I, Tholance Y, Rouaud O, Thomas-Anterion C, Croisile B, Mollion H, Moreaud O, Salzmann M, Dorey A, Bataillard M, Coste MH, Vighetto A, Krolak-Salmon P. Seguin J, et al. Among authors: mollion h. Neurology. 2011 May 24;76(21):1782-8. doi: 10.1212/WNL.0b013e31821ccc98. Epub 2011 Apr 27. Neurology. 2011. PMID: 21525425

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters